25%, environmental reasons in 10%, chromosome aberrations in 3% and factors such as drugs, infection and radiation exposure during pregnancy in about 3% (10).
. The use of metamizole sodium during pregnancy is classified as pregnancy category C. There is little information on precautions regarding metamizole use during pregnancy and its safety (14) . It is reported in the package insert of the drug that it passes the placenta but there is no evidence that it is harmful to the fetus. It does not show any teratogenic effect in rats or rabbits.
We investigated the effects of metamizole sodium on the neural tube at the early-stage chicken embryo model that complies with the first month of the embryonic development of the mammalian spine. █ 
MATERIAL and METHODS
A total of 40 fertilized chicken eggs of the Atabey® kind (Republic of Turkey Ministry of Agriculture, Ankara Poultry Institute) and free of specific pathogens were used for this study. The eggs were placed in the incubator in order to ensure the continuity of the embryos and to have them available at the times desired. The incubator was kept at a constant temperature range of 37.8 ± 0.2ºC and humidity of around 60-70%. The eggs were randomly divided into 4 groups. Group A was incubated for 48 hours without any additional procedure. The other eggs were opened with the windowing method at the 28 th hour of incubation (8 th stage according to the Hamburger-Hamilton staging). Physiological saline solution and metamizole sodium (Novalgin, Sanofi Aventis Ilaclari -Istanbul) were administered to the embryo with the in ovo method within a volume of 10 µL. Group B was only administered physiological saline. Group C was administered 1.8 mg metamizole sodium based on the drug's human therapeutic index (30 mg/kg). Group D was administered 5.4 mg metamizole sodium based on three times the dose (90 mg/ kg) according to the therapeutic index of metamizole sodium. The embryos were removed from the egg at the 48 th hour (12th stage according to the Hamburger-Hamilton staging).
All embryos were fixed with 10% buffered formalin for 48 hours. The neural tubes were examined under a stereomicroscope (Nikon, SZX 1000) to observe gross anatomy, and photographs were taken. Routine histological processing was used for the light microscopic examination of the embryos. After washing under tap water, dehydration was performed through graded alcohol series. The tissues were then made transparent with xylene and embedded into paraffin. Transverse serial sections 4 μm thick were obtained from the paraffin blocks with the Leica RM 2125RT microtome and stained with HematoxylinEosin (H-E). The preparations were evaluated using the Zeiss Axio Scope A1 light microscope by two histologists blinded to the groups and photographs were taken.
█ RESULTS
Group A: There were 16 somites and the neural tube was closed, stage 12 of the Hamburger-Hamilton classification, in 8 of the 10 chick embryos in the group ( Figure 1A ) while the neural tube was not closed in the other two embryos under the stereomicroscope. The tissue samples observed under the light microscope after staining with H-E were found to be consistent with the stereomicroscopic examination ( Figure  1B ).
Group B: We found that 9 of the 10 chick embryos administered physiological saline were at the expected embryonic stage according to the Hamburger-Hamilton classification. The neural tube was not closed in one embryo on stereoscopic examination. Light microscope findings were consistent with the stereomicroscope. Group D: One of the chick embryos died after the administration of metamizole sodium at 3 times the therapeutic index dose (90 mg/kg/day) and the neural tube was not closed in nine Figure 1A and stained with H-E. The neural tube is seen to be closed (B) (H-E, X40). Nt; neural tube, n; notochord, s; somites.
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embryos (Figure 4 A,B) . Developmental retardation was present in three embryos.
█ DISCUSSION
The primitive line, notochord and neural tube begin to develop from the 3rd week of the embryo. The spinal cord is formed with the development of the caudal part of the 4th pair of somites of the neural tube. Exposure to teratogens during this period of the pregnancy affects the development of neural tissue in the embryo and leads to developmental retardation of the neural tube (13) and its reopening after being formed or to neural tube rupture (6).
Metamizole sodium manufacture started in 1922. It was one of the most common analgesic and antipyretic drugs worldwide. It was then found to cause agranulocytosis and fatal complications in 1970. Its use was forbidden in Switzerland in 1974, the uSA in 1977 and in close to 30 other countries including Japan, Australia, Iran and some European Union countries in subsequent years. It is still a popular analgesic in some European (Germany, Russia, Poland) and other countries (Turkey, Brazil, Mexico, Israel, Egypt) and it is known to be used without a prescription in some countries.
Metamizole sodium is a drug with an analgesic and antipyretic effect but no anti-inflammatory component. It decreases prostaglandin biosynthesis by inhibiting cyclooxygenase-1 and cyclooxygenase-2 in the central nervous system (7) . It is thought to show its analgesic effect by decreasing prostaglandin synthesis through cyclooxygenase-3 enzyme inhibition in the spinal cord posterior horn (1, 11) . The molecular basis of neurulation is largely unknown. The embryo becomes less resistant to challenge by environmental stress when neurulation occurs. We think metamizole sodium may create stress in the embryo and block neurulation but the mechanism is unknown and further studies are needed.
Pregnant women who use metamizole can experience urticaria, hypotension, bronchospasm, and cardiac arrhythmia as side effects but the most severe ones are agranulocytosis and anaphylactic reactions. Agranulocytosis and anaphylactic 
A B
shock can be fatal. Some studies have investigated the connection between the use of metamizole sodium during pregnancy and the development of congenital anomalies. Administration of metamizole sodium to pregnant rats and evaluation of transplacental passage and carcinogenicity has shown no carcinogenicity (8) . Da Silva Dal Pizzol et al. investigated the presence of congenital anomalies, intrauterine death, preterm birth, and low birth weight in pregnant women who used metamizole sodium and found no relationship (4). Bar-Oz et al. compared 108 pregnant women who used metamizole sodium in the first trimester of pregnancy with pregnant women who used acetaminophen as a control group. Both groups were evaluated for birth weight and gestational age of the child, live birth rate, and spontaneous abortions. No significant difference was found between the incidence of major malformation in patients using metamizole (3%) and the control group (2%) (2). A weak connection was detected between metamizole sodium use during pregnancy and Wilms tumor in the child (12). Weintraub et al. reported oligohydramnios and ductus arterious stenosis in the fetus following metamizole sodium use in pregnant woman (14) . Some articles report the development of acute renal failure after the use of metamizole sodium in pregnant women (5) . It is clear from these articles that safety information regarding the use of metamizole sodium in pregnancy is inadequate. Its use in humans during pregnancy without more detailed investigations may not be as safe as it is believed. We believe that every effect of this drug that is used widely across the world should be studied in detail.
We did not come across a comprehensive article on the effects of metamizole sodium on neural tube development with a literature search. The neural tubes of the chick embryos were seen not to be closed with some embryos showing developmental retardation with a small number of somite formation even within the therapeutic dose range of metamizole sodium. Metamizole sodium administered at high doses was found to cause a neural tube defect, developmental retardation, and even death in the chick embryo. Metamizole sodium was therefore shown to cause a neural tube developmental defect in the chick embryo with teratogenic effects in this study. This study may set an example for future studies on the possible effect of metamizole sodium on the formation of neural tube defects in humans. Further studies on this matter are obviously needed in vivo, in vitro, and at the molecular level.
